Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4656-4668
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4656
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4656
Figure 1 Immunohistochemical staining for CC chemokine receptor type 8 in gastrointestinal stromal tumors.
A1: High cytoplasmic staining of CC chemokine receptor type 8 (CCR8) in the tissue microarray samples; A2: Specific high positive staining for CCR8 in the cytoplasm; B1: Low cytoplasm staining of CCR8 in gastrointestinal stromal tumor tissues; B2: Specific low positive staining for CCR8 in the cytoplasm; C1 and C2: Negative staining for CCR8. Original magnification: A1, B1, C1 × 40; A2, B2, C2 × 400.
Figure 2 Kaplan–Meier analysis of the relationships between clinicopathological features and overall survival in gastrointestinal stromal tumor patients.
A: Overall survival was significantly longer in patients with low CC chemokine receptor type 8 expression than in patients with high CC chemokine receptor type 8 expression; B: Patients with tumor diameter < 5 cm had a better prognosis than patients with diameter 5-10 or > 10 cm; C: Overall survival was significantly longer in patients with mitotic index 0-5 than in patients with mitotic index 6-10 or > 10.
- Citation: Li HL, Wang LH, Hu YL, Feng Y, Li XH, Liu YF, Li P, Mao QS, Xue WJ. Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors. World J Gastroenterol 2020; 26(31): 4656-4668
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4656.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4656